InVitria launches Optibumin® 25, the first recombinant 25% rHSA for closed-system use, enabling safer, scalable ...

Biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more ...

Exosomes, secreted by most cells, carry biological information and proteins that serve as noninvasive biomarkers for ...

Optibumin® 25 is the first recombinant 25% human serum albumin for closed-system biomanufacturing, offering consistency, sterility, and GMP compliance. For decades, plasma-derived HSA has ...

Despite the challenges associated with studying exosomes due to their low abundance, small size, and fragility, they are ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

Much of the work devoted to exploring potential sex-specific differences in exercise or sports performance has been derived ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in poster format at the American Association ...

Men have historically outperformed women in athletic competitions like the Olympic 100m races, while women dominate sports ...

The results of an open-label extension study confirmed the interchangeability of biosimilar CT-917 with reference adalimumab for plaque psoriasis.

Creative Diagnostics has announced Monkeypox Virus Neutralizing Antibody Test services for monkeypox research. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- As an expert in ...